Indo US Bio-Tech Ltd

Indo US Bio-Tech Annual Report

Indo Us Bio-Tech Ltd submitted its Annual Report for FY 2025-2026. The 22nd Annual General Meeting is scheduled for September 30, 2026.

Indo US Bio-Tech Annual General Meeting

Indo Us Bio-Tech Limited has issued a notice for its 22nd Annual General Meeting, scheduled for September 30, 2026, to be conducted via video conferencing.

Indo US Bio-Tech Board Meeting Outcome

Indo Us Bio-Tech Ltd announced outcomes of its board meeting, including the date for its 22nd AGM and appointment of statutory auditors.

Indo US Bio-Tech Q1 FY27 Results: Net Profit ₹3 Cr, Down 36.2% YoY

Indo US Bio-Tech Ltd reported revenue from operations of ₹33 Cr (+7.1% YoY) and net profit of ₹3 Cr (-36.2% YoY) for Q1 FY27.

Key figure

Net profit ₹3 Cr · -36.2% YoY

Indo US Bio-Tech Annual General Meeting

Indo Us Bio-Tech Limited announced the postal ballot results. Shareholders approved the appointment of a new director and statutory auditor.

Indo US Bio-Tech Board Meeting Date

Indo Us Bio-Tech Ltd scheduled a board meeting for August 12, 2026. The board will consider unaudited financial results for the quarter ended June 30, 2026.

Indo US Bio-Tech Board Meeting Outcome

Indo Us Bio-Tech announced a revised effective date for board committee reconstitutions. The changes reflect director appointments and resignations effective from April 21, 2026.

Indo US Bio-Tech Management Change

Indo Us Bio-Tech Limited appointed Bhagat & Associates as Statutory Auditor following Gautam N Associates' resignation. The change aligns with administrative restructuring of audit assignments.

Indo US Bio-Tech Other Announcement

Indo Us Bio-Tech reconstituted its Audit, Nomination, and Stakeholders committees effective July 10, 2026. This follows the earlier appointment of Hemanshi Darsh Soni as Additional Director.